The lethal segment has consistently commanded the largest revenue share within the Medium Caliber Ammunition Market, a position it solidified prominently in 2021 and has maintained through subsequent assessment periods. This dominance is rooted in structural military requirements: lethal medium caliber rounds are the primary munition type for a vast array of platforms including the Bradley Fighting Vehicle, the CV90 infantry fighting vehicle, the Puma IFV, naval 30 mm and 40 mm autocannons, and various rotary-wing attack platforms. These systems represent multi-decade platform commitments by national armed forces, ensuring a persistent, recurring demand signal for compatible lethal ammunition.
The lethal segment encompasses armor-piercing (AP), armor-piercing discarding sabot (APDS), high-explosive incendiary (HEI), and multi-purpose (MP) rounds. Each sub-variant serves a distinct tactical function, and modern military doctrines increasingly demand that ground forces carry mixed-lethality loads to engage both hardened and soft targets within the same engagement envelope. This tactical versatility has driven procurement of broader lethal round portfolios per platform, effectively expanding per-unit revenue capture for manufacturers.
Among the companies operating within this segment, General Dynamics Corporation maintains a formidable position through its Ordnance and Tactical Systems division, supplying 25 mm and 30 mm ammunition for U.S. Army and allied platforms. BAE Systems PLC leverages its Bofors heritage to supply 40 mm medium caliber rounds across European NATO members. Rheinmetall AG is a dominant force in 20 mm and 30 mm ammunition, benefiting from its integration with armored vehicle manufacturing, which creates captive platform-ammunition synergies. Northrop Grumman Corporation's ammunition systems unit supports key U.S. platforms including the M230 chain gun. Nammo AS, a Norwegian-Finnish joint venture, has expanded its lethal medium caliber portfolio significantly through R&D investment in programmable airburst munitions.
The lethal segment's share is not merely holding steady — it is consolidating. Several factors underpin this consolidation. First, geopolitical events since 2022, particularly the Russia-Ukraine conflict, have highlighted the critical importance of ammunition stockpile depth, prompting NATO members to issue multi-year replenishment contracts heavily weighted toward lethal variants. Second, the Artillery Ammunition Market and medium caliber sectors have seen parallel investment surges, with governments recognizing gaps across the full caliber spectrum. Third, modernization programs for infantry fighting vehicles across South Korea, India, Australia, and Poland are generating fresh platform introductions that carry lifetime ammunition supply commitments spanning 10 to 30 years.
Non-lethal variants, while growing, currently represent a modest revenue fraction. Their growth is predominantly driven by law enforcement agencies, border security forces, and peacekeeping mission requirements rather than conventional military procurement. The technological barrier to developing effective non-lethal medium caliber solutions that are safe for operators and compliant with international humanitarian law standards also limits rapid market penetration. Consequently, investment flows and OEM production capacity remain disproportionately oriented toward lethal applications, cementing this segment's dominant market position for the foreseeable forecast period.
The lethal segment's resilience is further reinforced by the fact that ammunition is a consumable asset. Unlike platforms, which have replacement cycles measured in decades, ammunition is expended in training, exercises, and combat operations, creating a recurring revenue model that is relatively insulated from platform procurement budget cycles. This consumable nature provides manufacturers with predictable demand floors and enables long-term production planning aligned with defense ministry framework agreements.
